Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07217405 · ClinicalTrials.gov registry record · Phase 4

Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis

A Phase 4 study of Osteoarthritis Hand and Osteoarthritis Wrist, sponsored by Mayo Clinic.

Recruiting
Registry status
Phase 4
Development phase
165
Enrollment target
1
Study location

NCT07217405 is a Phase 4 study of Osteoarthritis Hand and Osteoarthritis Wrist that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 165 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07217405, a Phase 4 study of Osteoarthritis Hand and Osteoarthritis Wrist, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
Phase 4
Development phase
165 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to compare low-dose radiotherapy to corticosteroid injection for treatment of hand/wrist osteoarthritis.

Interventions

  • DRUG Corticosteroid injection (CSI)
  • RADIATION Low-dose radiotherapy (LDRT)

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2025-12-19
Est. Completion 2027-10-01
Phase Phase 4

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07217405

The ClinicalTrials.gov registry entry for NCT07217405 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Osteoarthritis Hand appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid injection (CSI) is the first listed.

NCT07217405 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07217405 about?

NCT07217405 is a clinical study titled "Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis". The purpose of this research is to compare low-dose radiotherapy to corticosteroid injection for treatment of hand/wrist osteoarthritis.

What is the current status of trial NCT07217405?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 165 participants. The study started on 2025-12-19. Estimated completion is 2027-10-01.

What conditions does trial NCT07217405 study?

This clinical trial studies the following conditions: Osteoarthritis Hand, Osteoarthritis Wrist.

What interventions are being tested in trial NCT07217405?

The interventions under investigation include: Corticosteroid injection (CSI) (DRUG), Low-dose radiotherapy (LDRT) (RADIATION).

Who is sponsoring clinical trial NCT07217405?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07217405 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis Hand

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.